Game theory explains why reasonable parents make vaccine choices that fuel outbreaks

Vaccine hesitancy isn’t a moral failure – it’s a property of a system in which people must balance personal and collective ...
WKRN-TV

Inside the Vanderbilt lab tasked with testing vaccine safety

NASHVILLE Tenn. (WKRN) — It can take more than a decade to develop a new vaccine for children. After years of research and testing, some don’t pass the safety checks. One laboratory at Vanderbilt ...
Nasdaq

Evaxion A/S Launches EVX-B4 Vaccine Development Program Targeting Group A Streptococcus Infections

Evaxion A/S has announced the initiation of a new vaccine program, EVX-B4, targeting Group A Streptococcus (GAS), a pathogen responsible for a wide range of infections globally, including severe ...
Nasdaq

Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1

COPENHAGEN, Denmark, November 12, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, announces new ...
Managed Healthcare Executive

Low uptake of shingles vaccine despite strong value proposition for older adults

RZV offers substantial clinical and economic benefits but has low uptake among adults aged 50 and older compared to other vaccines. By 2020, only 10.8% of adults aged 50 and older had completed both ...